For many in the device space, perseverance is an absolutely essential quality, the quality from which all else flows, and few people in this industry better exemplify the spirit and virtues of perseverance than Karen Talmadge, PhD, now executive vice president, co-founder and chief science officer at Kyphon, a spine company with a truly novel technology that today has a market cap of more than a billion dollars.
By David Cassak
It's often been said that success has many parents, but failure is an orphan. For a select few, success comes...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
An interactive look at pharma, medtech and diagnostics deals made during May 2025. Data courtesy of Biomedtracker.
Flagship Pioneering senior partner Raj Panjabi discusses shifting health care from reactive treatment to AI-powered prediction and prevention of disease before symptoms emerge.
Namrata Saroj, chief business officer of Ocular Therapeutix, is highly respected in the retina community for her contributions to drug development. She talked to In Vivo about her journey in ophthalmology, leadership philosophy and the importance of authenticity in a close-knit specialty.
